FDA Adverse Event Malfunction Summary report: N

NUVASIVE XLIF INSTRUMENTS

MDR report key: 16758654 · Received April 17, 2023

Report

Report Number
2031966-2023-00088
Event Type
Malfunction
Date Received
April 17, 2023
Date of Event
March 13, 2023
Report Date
April 17, 2023
Manufacturer
NUVASIVE, INC.
Product Code
LXH
UDI-DI
00887517452764
PMA / PMN Number
EXEMPT
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE COMPLAINT DEVICE WAS EVALUATED AND THE REPORTED EVENT WAS CONFIRMED. THE EVALUATION IDENTIFIED THE DISTAL TIP OF THE PITUITARY WAS SHEARED OFF AND DAMAGED, INDICATIVE OF EXCESSIVE FORCE APPLIED TO THE INSTRUMENT. OPERATIVE NOTES AND/OR RADIOGRAPH IMAGES WERE NOT PROVIDED FOR REVIEW OF USAGE/TECHNIQUE. A REVIEW OF DEVICE MANUFACTURING RECORDS WAS PERFORMED AND NO DISCREPANCIES WERE FOUND. A DEFINITIVE ROOT CAUSE WAS UNABLE TO BE DETERMINED WITH THE INFORMATION PROVIDED BUT IS LIKELY THE RESULT OF EXCESSIVE USE OF FORCE OR TECHNIQUE. LABELING REVIEW: RESIDUAL RISKS TO THE PATIENT ASSOCIATED WITH USE OF GENERAL SURGICAL INSTRUMENTS ARE: INSTRUMENT MALFUNCTIONS WHICH POTENTIALLY RESULT IN SURGICAL DELAYS (THEREBY CAUSING ADDITIONAL EXPOSURE TO ANESTHESIA, BLOOD LOSS, AND INFECTION). A CHANGE IN SURGICAL PLAN, FAILURE TO ACHIEVE OPTIMAL CLINICAL RESULT AND/OR, INFREQUENTLY, CANCELLATION OF A PROCEDURE. SUCH MALFUNCTIONS INCLUDE INSTRUMENT FRACTURE, WHICH COULD MAKE NECESSARY REMOVAL DIFFICULT OR SOMETIMES IMPOSSIBLE, WITH POSSIBLE CONSEQUENCES OF LATE INFECTION AND MIGRATION; INSTRUMENT FRACTURE MAY ALSO RESULT IN INJURY TO THE PATIENT. RESIDUAL RISKS TO SURGICAL STAFF ASSOCIATED WITH USE OF GENERAL SURGICAL SYSTEMS ARE: INSTRUMENT FAILURES OR MALFUNCTIONS WHICH PREVENT INTENDED USE, RESULTING IN DECREASED OPERATIONAL EFFICIENCY AND GENERAL INCONVENIENCE. PRE-OPERATIVE WARNINGS: THE METHOD OF USE FOR THE INSTRUMENTS ARE TO BE DETERMINED BY THE USER¿S EXPERIENCE AND TRAINING IN SURGICAL PROCEDURES. THE INSTRUMENTS SHOULD BE TREATED AS ANY PRECISION INSTRUMENT AND SHOULD BE CAREFULLY PLACED ON TRAYS, CLEANED AFTER EACH USE, AND STORED, ACCORDING TO GENERALLY ACCEPTED HOSPITAL METHODS AND PRACTICES. THE INSTRUMENTS SHOULD BE CAREFULLY EXAMINED PRIOR TO USE FOR FUNCTIONALITY, EXCESSIVE WEAR, OR DAMAGE. A DAMAGED INSTRUMENT SHOULD NOT BE USED AS THIS MAY INCREASE THE RISK OF MALFUNCTION AND POTENTIAL PATIENT INJURY. INTRA-OPERATIVE WARNINGS: THE PHYSICAL CHARACTERISTICS REQUIRED FOR MANY INSTRUMENTS DO NOT PERMIT THEM TO BE MANUFACTURED FROM IMPLANTABLE MATERIALS. IF ANY BROKEN FRAGMENTS OF INSTRUMENTS REMAIN IN THE BODY OF A PATIENT, THEY COULD CAUSE ALLERGIC REACTIONS OR INFECTIONS. IF AN INSTRUMENT BREAKS IN SURGERY AND FRAGMENTS GO INTO THE PATIENT, THESE PIECES SHOULD BE REMOVED PRIOR TO CLOSURE AND SHOULD NOT BE IMPLANTED. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT A SPINAL PROCEDURE. DURING THE PROCEDURE, THE DISTAL ARTICULATING TIP OF THE PITUITARY RONGEUR FRACTURED OFF. THE PIECE WAS RETRIEVED AND WAS NOT RETAINED IN THE PATIENT. NO FURTHER PATIENT OR PROCEDURE IMPACT WAS REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
413282 NUVASIVE XLIF INSTRUMENTS ORTHOPEDIC MANUAL SURGICAL INSTRUMENT LXH NUVASIVE, INC. 6940429 FD8908616 00887517452764

Patients

Seq Age Sex Outcome Treatment
1 Prefer Not To Disclose